178765-55-4 Usage
Uses
Used in Skincare Industry:
12-Hydroxyisobakuchiol is used as an anti-aging and skin-improving ingredient for its ability to mimic the benefits of retinol without causing irritation. It is particularly valued for its potential to reduce the appearance of fine lines, wrinkles, and uneven skin tone, promoting a smoother and more youthful complexion.
Used in Cosmetic Industry:
In the cosmetic industry, 12-Hydroxyisobakuchiol is utilized for its anti-microbial and anti-oxidant properties, which can help protect the skin from environmental stressors and support overall skin health. Its inclusion in cosmetic products may contribute to a more resilient and radiant appearance.
Used in Pharmaceutical Industry:
12-Hydroxyisobakuchiol is studied for its potential applications in the treatment of inflammatory and oxidative stress-related diseases, given its anti-inflammatory and anti-oxidant capabilities. This suggests that it could be a valuable component in developing therapeutic agents for various health conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 178765-55-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,8,7,6 and 5 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 178765-55:
(8*1)+(7*7)+(6*8)+(5*7)+(4*6)+(3*5)+(2*5)+(1*5)=194
194 % 10 = 4
So 178765-55-4 is a valid CAS Registry Number.
178765-55-4Relevant academic research and scientific papers
Synthesis and structure-immunosuppressive activity relationships of bakuchiol and its derivatives
Chen, Hongli,Du, Xiaolong,Tang, Wei,Zhou, Yu,Zuo, Jianping,Feng, Huijin,Li, Yuanchao
, p. 2403 - 2411 (2008/09/21)
A series of derivatives of bakuchiol were synthesized and tested in vitro for their cytotoxicity, and inhibition of T cell proliferation and B cell proliferation. The data obtained provided preliminary structure-activity relationships of the compounds as immunosuppressive activity.
